Personalis Inc   (PSNL)
Other Ticker:  
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
Price: $1.3600 $0.04 3.030%
Day's High: $1.3892 Week Perf: 1.49 %
Day's Low: $ 1.25 30 Day Perf: -16.05 %
Volume (M): 433 52 Wk High: $ 3.27
Volume (M$): $ 589 52 Wk Avg: $1.86
Open: $1.27 52 Wk Low: $0.89

 Market Capitalization (Millions $) 66
 Shares Outstanding (Millions) 49
 Employees -
 Revenues (TTM) (Millions $) 71
 Net Income (TTM) (Millions $) -113
 Cash Flow (TTM) (Millions $) -11
 Capital Exp. (TTM) (Millions $) 17

Personalis Inc
Personalis Inc is a biotechnology company based in California, United States. The company specializes in advanced genomics and precision medicine, providing genomic sequencing and analysis solutions to support the development of personalized therapies and precision diagnostics.

Personalis uses its proprietary ACE (Accuracy and Content Enhanced) technology to generate accurate and comprehensive genomic data, which can help researchers and healthcare professionals in the discovery and development of therapies. The company's technology can analyze complex genomes, including cancer genomes, and provides insights into disease biology, immune response, and drug sensitivity.

Personalis also offers a range of services, including cancer genomics, clinical genetics, and population genomics. Their services help researchers and clinicians understand the individual variations in genome sequences and interpret their impact on health conditions and diseases.

The company has partnerships with pharmaceutical and biotech companies, academic institutions, and research organizations to collaborate on various genomics research projects. It has a strong focus on translating genomic data into actionable information that can improve patient care and outcomes.

Overall, Personalis Inc plays a crucial role in advancing precision medicine by leveraging genomic analysis to provide personalized insights into disease biology and treatment options.

   Company Address: 6600 Dumbarton Circle Fremont 94555 CA
   Company Phone Number: 752-1300   Stock Exchange / Ticker: NASDAQ PSNL
   PSNL is expected to report next financial results on February 22, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Personalis Inc

Personalis Inc Shatters Expectations with Astounding 22.8% Revenue Surge in Q3 2023

In the fast-paced world of the stock market, it is always exciting to come across companies that demonstrate exceptional growth and potential. One such company that has recently caught the attention of investors is Personalis Inc, a leading player in the Medical Laboratories sector.
Personalis Inc announced its third-quarter results for 2023, and the numbers are truly impressive. The company experienced a surge in revenue by a staggering 22.809%, reaching an impressive $18.25 million. This growth is even more remarkable when compared to its sector peers, as the Medical Laboratories sector only showed a 3.78% increase in revenue during the same period.

Personalis Inc

Personalis Inc Experiences Revenue Regression Throughout Q2, 2023 Financial Report

Personalis Inc, a prominent medical laboratories company, reported its financial results for the April to June 2023 interval. The period witnessed a decrease in turnover leading to fading revenue and a greater loss. Additionally, the company has experienced a decline in accounts receivable, which some analysts attribute to slowing demand. This article aims to analyze these financial results and contextualize them within the company's overall performance.
Financial Results: Decreased Revenue and Greater Loss
In the second quarter of 2023, Personalis Inc reported a loss per share of -$0.50, exhibiting a significant improvement from the previous year's -$0.61 per share. However, revenue fell by 8.448% to $16.70 million, compared to the same period last year when revenue stood at $18.86 million. The Company faced challenges in generating revenue, resulting in a greater overall loss.


Personalis Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com